Valeant Pharmaceutical's $825 million acquisition of Amoun Pharmacuticals

19/10/2015
Public acquisition

$ 825 million

Completed

19/10/2015


Overview:

  • Valeant Pharmaceutical acquired Amoun Pharmacuticals for $825 million from Citi Venture Capital, Capital International and Concord International.
  • Concord International is a fund manager groups including Capital, Ethemba, the Rohatyn Group and Concord.
  • Amoun Pharmacuticals is a significant pharmaceutical company in Egypt. 

Rani Mehta - Journalist 

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in